Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer

Publisher： Karger

E-ISSN： 1423-0232|56|1|46-53

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.1, 1999-01, pp. : 46-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

By  

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 115-115

Karger

Access to resources Recommend Favorite

Recombinant human epoetin beta in the treatment of renal anemia

By Del Vecchio Lucia   Cavalli Andrea   Pozzoni Pietro   Locatelli Francesco  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 91-98

Future Medicine

Access to resources Recommend Favorite

HX575, Recombinant Human Epoetin Alfa, for the Treatment of Chemotherapy-Associated Symptomatic Anaemia in Patients with Solid Tumours

By  

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 216-221

Karger

Access to resources Recommend Favorite

Erythropoietin Response to Anemia as a Function of Age

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 1, 1991-01 ,pp. : 30-32

John Wiley & Sons Inc

Access to resources Recommend Favorite